Clinical Trials Browser

Phase 1/2 × Carcinoma, Transitional Cell × durvalumab × Clear all

Carcinoma, Transitional Cell

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell